PSA:154-163(155L) peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-016274
A cancer vaccine comprised of a synthetic peptide with an amino acid sequence corresponding to positions 154-163 of the amino acid sequence for prostate-specific antigen (PSA) with a leucine substitution at position 155. Upon administration, PSA:154-163(155L) peptide vaccine may elicit a cytotoxic T-cell response against tumor cells that express PSA.
| Identifier | MLC-T-ONC-016274 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | PSA PEP VAC |
| Synonyms | PSA-3A |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016274",
"term": "PSA:154-163(155L) peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine comprised of a synthetic peptide with an amino acid sequence corresponding to positions 154-163 of the amino acid sequence for prostate-specific antigen (PSA) with a leucine substitution at position 155. Upon administration, PSA:154-163(155L) peptide vaccine may elicit a cytotoxic T-cell response against tumor cells that express PSA.",
"abbreviation": "PSA PEP VAC",
"synonyms": [
"PSA-3A"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/psa-154-163-155l-peptide-vaccine/"
}
Record 13,803 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.